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A very stable binding site for the interaction between an pentameric oligothiophene
and an amyloid-β(1–42) fibril has been identified by means of non-biased molecular
dynamics simulations. In this site, the probe is locked in an all-trans conformation with
a Coulombic binding energy of 1,200 kJ/mol due to the interactions between the anionic
carboxyl groups of the probe and the cationic ε-amino groups in the lysine side chain.
Upon binding, the conformationally restricted probes show a pronounced increase in
molecular planarity. This is in-line with the observed changes in luminescence properties

























Amyloid fibrils are pathological hallmarks of a number of human neurodegenerative dis-
eases such as Alzheimer’s and Parkinson’s.1–3 These fibrils are shown to interact with lumi-
nescent conjugated oligothiopene (LCO) biomarkers, enabling an early-stage, specific, detec-
tion of the associated diseases4–8 as the LCOs have proven to distinguish between separate
morphotypes of protein aggregation that are related to different heterogeneous phenotypes.6
To achieve rational biomarker design, however, it is indispensable to have a detailed mi-
croscopic knowledge of the binding between the biomarker and the amyloid fibril. Although
in principle well suited for theoretical studies, simulations of the binding site have been
hampered by a lack of knowledge of fibrillar structures. Recent advances in the structural
biology have changed this situation,9 allowing us to perform large-scale non-biased molecular
dynamics simulations of the binding of LCOs to amyloid fibrils. Adopting one of the proto-
typical anionic LCOs, our simulations reveal a binding site that convincingly reproduces all
currently known experimental observations and we believe that it is representative for this
class of probes.
The recent experimental fibrillar structure studies all give evidence for a double-stack of
amyloids that is tilted9–12 but differ in their predictions of the relative stack positions. Refs.
10,11 are based on nuclear magnetic resonance (NMR) measurements and find a flexible and
non-structured terminus. In contrast, the structure obtained from cryo-electron microscopy
(cryo-EM) reported in Ref. 9 shows a very ordered organization of the entire protein. This
study furthermore provides a direction for the tilt and suggests an approximate 21 screw
symmetry.
Earlier docking studies include (i) the work by Schütz et al. investigating the interactions
between Congo red,13 a more standard amyloid biomarker, and amyloid fibrils formed by
the prion domain of the fungal HET-s protein as well as (ii) the work by Herrmann et al.
investigating the interactions between the LCO adopted here14 (see molecular structure in
Figure 1) and a misfolded and aggregated form of the cellular prion protein (PrPC). Both
these studies showed significant interactions between the negatively charged sulfonate and
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carboxyl moieties of the probes, respectively, and the positively charged lysine residues of
the respective protein models. In contrast and comparison to these earlier studies, we apply
a non-biased and fully theoretical approach using the recently discovered tilted structure of
the amyloid fibril.9
We have constructed the structural model from one chain of the PDB entry 5OQV.9
We duplicated this chain multiple times and applied the approximate 21 screw symmetry
reported in Ref. 9. With 253 chains we obtained a one-half helix turn, allowing us to
apply periodic boundary conditions. We optimized the chain–chain distance with help of
a semi-isotropic barostat to accommodate the room temperature expansion as compared
to the ultra-cold conditions in which the structure was obtained.9 We thereby obtained a
simulation box of ca. 63 nm along the axis of the fibril, corresponding to a pitch of 126 nm
for the amyloid fibril helix. The model proved stable in our molecular dynamics simulations
lasting up to 9.8 ns. Based on this structure, we generated a simulation box containing
the fibril and 61 tracked LCO probes in a similar fashion. After NPT -equilibration, we
performed a NV T -simulation for 40 ns on the full system. The computational details for
the molecular dynamics simulations with Gromacs15–17 as well as the applied force fields18–22
and more details concerning the model setup and supporting calculations23–26 can be found
in the supplementary information.
After only a few nanoseconds of simulation time, some of the chromophores started to
bind to the amyloid fibril. All observed binding processes are initially governed by electro-
static interactions of the negatively charged carboxyl groups of the probe with positively
charged side chains on the surface of the amyloid fibril. This is in a vast majority of the
cases the lysine 16 group. Once, the connection is established, the probe stays very local to
its original interaction site. At later stages, we observe that the probes lie flat down on the
protein surface, which gives rise to additional hydrophobic (Lennard-Jones) binding energy
between the probe and the amyloid fibril. An example of this binding behavior is illustrated
in Figure S-3 in the supplementary material.
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After 40 ns, we found 25 LCO probes with significant short-range Coulomb interaction
with the fibril and 22 of these were located at the lysine 16 interaction side, as highlighted in
Figure 1 with the VAMD visualization environment (see details in supplementary informa-
tion). The other three LCO molecules binded via electrostatic interactions with the arginine
















Figure 1: Top: Structure illustration of adopted LCO probe named p-FTAA. Bottom: Simu-
lation snapshot after 40 ns. The protein and lysine 16 groups are depicted in blue and green,
respectively. Probes showing large short-range Coulombic interactions with the fibril are
highlighted. The red shaded areas show density volumes for probes with Coulombic binding
energies and planarities exceeding 500 kJ/mol and 2.5, respectively.
To quantify the overall behavior of the probes over time, we studied the system over the
last nanosecond of the simulation, i.e., from 39–40 ns in real time. In Figure 2, we present
the correlation of the different properties of interest with the Coulomb binding energy for
all monitored probes separately and within this time-window. Time-averaged quantities
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are shown with filled circles and bars mark the corresponding root-mean-square (RMS)
deviations.
The upper panel of Figure 2 shows the correlation between the Coulomb binding energy
between the individual probes and the protein and the corresponding Lennard-Jones binding
energy. We can clearly identify three different categories of probe molecules: (i) Colored in
green and red, the 22 probe molecules bound to the lysine 16 group with average Coulomb
binding energies in the range of 500–1200 kJ/mol and Lennard-Jones binding energies ranging
up to 80 kJ/mol; (ii) Colored in blue, the three probes interacting with the arginine 5 group,
showing Coulomb binding energies of 50–300 kJ/mol and Lennard-Jones binding energies
ranging up to 20 kJ/mol; (iii) Colored in black, the unbound probes that have no interaction
energy energies, are collectively represented by a single black dot. We note that probes with
strong Coulombic binding also have sizable Lennard-Jones binding energies, but that there
is no clear correlation between the two energy contributions for probes within any of the
three categories.
The mid panel of Figure 2 shows the correlation between the Coulomb binding energy
and the number of trans-dihedral S–C–C–S angles in the probe. We observe a pronounced
increase in the number of trans-dihedral angles for the category of probes bound to lysine
16.
Table 1: Time-averaged planarity and number of trans-dihedral angles together with the
respective RMS deviations. Results are presented for the different categories of probes over
the time range from 39 to 40 ns. Converged results for a single probe in aqueous solution
are provided as well as results for the strongly bound p-FTAA probe for the large and small
model system.
no. mol time (ns) planarity no. trans
Single p-FTAA in water 1 100 2.45±0.39 2.16±0.94
Bound LCOs to LYS16 22 1 2.49±0.40 3.07±0.97
Bound LCOs to ARG5 3 1 2.40±0.37 2.21±0.85
Unbound LCOs 36 1 2.43±0.38 2.14±0.95
Bound p-FTAA in large model 1 1 2.79±0.28 4.00±0.00
Bound p-FTAA in large model 1 23.4 2.83±0.29 4.00±0.06



























Figure 2: Correlation of Coulomb binding energy with (i) the Lennard-Jones binding energy
(LJ, top), (ii) number of trans dihedral angles (middle), and (iii) planarity (bottom) for all
61 tracked probes. Circles show averages over simulation time region 39–40 ns and bars
represent RMS deviations. The grey areas mark reference data for a single probe in water.
The lower panel of Figure 2 shows the correlation of probe planarity, as defined in Ref.
27, with respect to the Coulomb binding energy. For a given molecular probe configuration,
this planarity measure results in a value between 0 and 4, corresponding to having all four
dihedral angles equal to 90◦ and 0◦ or 180◦, respectively. As reference, the solid horizontal
gray line and shaded light gray area represents that averaged planarity and its RMS deviation
for a 100 ns single-probe trajectory in aqueous solution—their values are listed in Table 1
as equal to 2.45 and 0.39, respectively. From the data in the table, one can conclude that
there is no statistical significant changes in planarity to be found for any of the three probe
categories in comparison with the reference results for an isolated probe in aqueous solution.
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This stands in contrast with the experimental observations of red-shifted excitation spectra
associated with increasing planarity,27 so clearly none of the ensemble categories of probes
can provide a realistic representation of the probe-to-fibril binding.
Figure 3: Strongest binding motif from different viewpoints. Positively charged lysine 16
groups are shown in green and the hydrophobic side chains of valine 18 and phenylanaline
20 in blue and orange respectively.
However, within the category of lysine 16 bound probes, one LCO stands out, namely
the one highlighted in red in Figure 2 and henceforth referred to as p-FTAA∗. This binding
conformation is depicted in Figure 3 and has a Coulomb binding energy as high as 1200±100
kJ/mol combined with a short-range Lennard-Jones binding energy of 70±20 kJ/mol. As
presented in Figure 3, this binding site contains in addition to the positive lysine 16 groups
interacting with the carboxyl groups of the LCO also two hydrophobic side-chains, namely
valine 18 and phenylalanine 20—the side-chains for the residues 17 and 19 are pointing
inwards the fibril and are therefore not shown.
Compared to the other lysine-bonded probes, p-FTAA∗ exhibits higher degrees of pla-
narity and trans-conformation as seen in Table 1. With reference to aqueous solution, the
planarity of p-FTAA∗ is increased by 0.3–0.4. The binding conformation is very stable and
once formed it was never observed to disintegrate during the full simulation time. To collect
further evidence for the stability of this binding site, we performed longer molecular dynam-
ics simulations on a smaller model system (see Figure S-2 in the supplementary material).
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Using this reduced-size system, we could afford a simulation time exceeding 60 ns, during
which the p-FTAA∗ conformation remained stable. The statistics from this simulation are
shown at the bottom row of Table 1 and they are seen to be in perfect agreement with those
obtained in the shorter simulation of the full system (table row above). Hence, we con-
sider these molecular dynamics simulations converged and it is with some confidence that
we present this as the main binding site for anionic LCO probes interacting with amyloid
fibrils.
The proposed binding site is in agreement with experimental observations on multiple
accounts:
• The UV-vis absorption spectrum of the bound LCO probe is shifted by about 30 nm
(0.19 eV).8 Previous work27 reports on a correlation between the planarity and the
absorption maximum of LCO dyes in water. For p-FTAA, a linear fit with a slope of
53.5 nm is obtained (see Figure S-4 in the supplementary material), which, with an
increased planarity for p-FTAA∗ of about 0.3–0.4, corresponds to a red-shift of about
15–20 nm. This rough estimate points into the right direction, leaving out important
aspects in the spectrum calculation such as effects of vibrations, conformational re-
striction in the binding site, and electronic polarization due to the environment. Such
an extensive spectrum study lies beyond the scope of the present communication.
• It is known that the spacing between the carboxyl groups is essential for spectral dis-
crimination of different fibrils.7 This finding suggests a regular and specific interaction
of the carboxyl groups with the fibril, just as we observe in every single binding event
in this study.
• The interactions between negatively charged probe groups and lysine have been pro-
posed before as main interaction sites for both Congo-red13 and LCO probes14,28 in
combination with prions. These results were obtained from evidence-based docking,
based on more approximate structures than what we employ in the present study.
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In summary, we propose a site for the binding of anionic luminescence biomarkers with
amyloid-β(1–42) fibrils based on non-biased molecular dynamics simulations. The found
binding site is very stable, leading to conformational restrictions of the probe that are in
qualitative agreement with observed spectroscopic shifts upon the aggregation of LCO probes
with a recombinant Aβ(1–42) peptide.8 Convinced that we have found a realistic binding
site for this class of probes, we believe that this elucidation of the probe–protein interactions
on atomistic level will be crucial for the rational design of future and improved biomarkers
for amyloid fibrils.
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